Nona Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Nona Biosciences's estimated annual revenue is currently $6M per year.
- Nona Biosciences's estimated revenue per employee is $155,000
Employee Data
- Nona Biosciences has 39 Employees.
- Nona Biosciences grew their employee count by 144% last year.
Nona Biosciences's People
Name | Title | Email/Phone |
---|---|---|
1 | Executive Director/Head Biology | Reveal Email/Phone |
2 | Executive Direcror Head Business Deveopment | Reveal Email/Phone |
3 | Marketing Specialist | Reveal Email/Phone |
Nona Biosciences Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Nona Biosciences?
Nona Biosciences is a global biotechnology company committed to providing a total solution for partners worldwide, from academies, biotech startups to biopharma giants. The integrated antibody discovery services range from antigen preparation, animal immunization, single B cell screening, to antibody lead generation and engineering, developability assessment and pharmacological evaluation, leveraging the advantages of Harbour Mice® platforms and the experienced therapeutic antibody discovery team. \nHarbour Mice® generates fully human monoclonal antibodies in two heavy and two light chains (H2L2) format, as well as heavy chain only (HCAb) format. Integrating Harbour Mice® and a single B cell cloning platform, Nona Biosciences is focused on driving global inventions of transformative next-generation drugs by diversified partnership strategies including co-discovery, platform and antibody discovery, and platform license. The values of the antibody discovery platforms and flexible partnership models have been well validated by more than 50 industry and academic partners within over 200 projects.
keywords:N/AN/A
Total Funding
39
Number of Employees
$6M
Revenue (est)
144%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $8.4M | 39 | -11% | N/A |
#2 | $3M | 39 | -22% | $77.6M |
#3 | $3.9M | 39 | 50% | $1.5M |
#4 | $4.7M | 39 | -13% | N/A |
#5 | $7.8M | 39 | 39% | N/A |